Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 376

1.

[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].

Pérez A, González Blanco C, Hernández-Presa MÁ, Chaves J.

Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005. Spanish.

PMID:
21641286
2.

Management of dyslipidemia in diabetes.

Solano MP, Goldberg RB.

Cardiol Rev. 2006 May-Jun;14(3):125-35. Review.

PMID:
16628021
3.

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.

Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ; DYSIS Investigators.

Eur J Prev Cardiol. 2012 Apr;19(2):221-30. doi: 10.1177/1741826711400545. Epub 2011 Mar 10.

PMID:
21450578
4.
5.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

6.

[Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].

Brath H, Wascher TC, Kästenbauer T, Toplak H.

MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:41-7. German.

PMID:
23424754
7.
10.

Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.

Poussa H, Strandberg TE, Tikkanen I, Kauhanen P, Lepäntalo M.

Scand Cardiovasc J. 2007 Jun;41(3):138-41.

PMID:
17487761
11.

Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.

Pratipanawatr T, Rawdaree P, Chetthakul T, Bunnag P, Ngarmukos C, Benjasuratwong Y, Leelawatana R, Kosachunhanun N, Plengvidhya N, Deerochanawong C, Suwanwalaikorn S, Krittiyawong S, Mongkolsomlit S, Komoltri C.

J Med Assoc Thai. 2006 Aug;89 Suppl 1:S60-5.

PMID:
17715835
12.

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.

PMID:
17919548
13.

Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.

Gitt AK, Jünger C, Smolka W, Bestehorn K.

Clin Res Cardiol. 2010 Nov;99(11):723-33. doi: 10.1007/s00392-010-0177-z. Epub 2010 Jun 3.

14.

Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.

Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.

Eur J Intern Med. 2009 Mar;20(2):197-200. doi: 10.1016/j.ejim.2008.06.009. Epub 2008 Aug 15.

PMID:
19327612
15.

Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.

Jaussi A, Noll G, Meier B, Darioli R.

Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):363-72. doi: 10.1097/HJR.0b013e328333c1d9.

PMID:
20168234
16.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators.

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
17.

Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.

Kondo Y, Hamai J, Nezu U, Shigematsu E, Kamiko K, Yamazaki S, Yoshii T, Takahashi M, Takano T, Kawasaki S, Yamada M, Yamakawa T, Terauchi Y.

Endocr J. 2014;61(4):343-51. Epub 2014 Jan 22.

18.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators.

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
19.

Statin therapy and cataract in type 2 diabetes.

Hermans MP, Ahn SA, Rousseau MF.

Diabetes Metab. 2011 Apr;37(2):139-43. doi: 10.1016/j.diabet.2010.09.005. Epub 2010 Dec 8.

PMID:
21145274
20.

Supplemental Content

Support Center